Journal of Commercial Biotechnology http://www.palgrave-journals.com/jcb/current_issue/ Palgrave Macmillan Ltd en Copyright © Palgrave Macmillan Ltd Journal of Commercial Biotechnology 1462-8732 Copyright © Palgrave Macmillan Ltd rights@palgrave.com Journal of Commercial Biotechnology http://www.palgrave-journals.com/pal/images/logos_b_o_w/jcb.gif http://www.palgrave-journals.com/jcb/ Continuing education in biotechnology http://dx.doi.org/10.1057/jcb.2008.30 Continuing education in biotechnology

Journal of Commercial Biotechnology 14, 275 (October 2008). doi:10.1057/jcb.2008.30

Author: Yali Friedman

]]> Continuing education in biotechnology Yali Friedman doi:10.1057/jcb.2008.30 Journal of Commercial Biotechnology 14, 275 (October 2008) Journal of Commercial Biotechnology 14 4 275 276 Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies http://dx.doi.org/10.1057/jcb.2008.22 Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies

Journal of Commercial Biotechnology 14, 277 (October 2008). doi:10.1057/jcb.2008.22

Authors: Arlen D Meyers, Donald J McCubbrey, Richard T Watson &

]]> Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies Arlen D Meyers Donald J McCubbrey Richard T Watson doi:10.1057/jcb.2008.22 Journal of Commercial Biotechnology 14, 277 (October 2008) June 17, 2008 Journal of Commercial Biotechnology June 17, 2008 14 4 277 281 Can compliance help marketing and business development? http://dx.doi.org/10.1057/jcb.2008.29 Can compliance help marketing and business development?

Journal of Commercial Biotechnology 14, 283 (October 2008). doi:10.1057/jcb.2008.29

Author: John Avellanet &

]]> Can compliance help marketing and business development? John Avellanet doi:10.1057/jcb.2008.29 Journal of Commercial Biotechnology 14, 283 (October 2008) Journal of Commercial Biotechnology 14 4 283 286 Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers http://dx.doi.org/10.1057/jcb.2008.25 Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

Journal of Commercial Biotechnology 14, 287 (October 2008). doi:10.1057/jcb.2008.25

Authors: Laura Heinonen, Birgitta Sandberg &

]]> Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers Laura Heinonen Birgitta Sandberg doi:10.1057/jcb.2008.25 Journal of Commercial Biotechnology 14, 287 (October 2008) June 24, 2008 Journal of Commercial Biotechnology June 24, 2008 14 4 287 298 Got value? Determine it. Demonstrate it. Communicate it. Realise it http://dx.doi.org/10.1057/jcb.2008.7 Got value? Determine it. Demonstrate it. Communicate it. Realise it

Journal of Commercial Biotechnology 14, 299 (October 2008). doi:10.1057/jcb.2008.7

Authors: Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras &

]]> Got value? Determine it. Demonstrate it. Communicate it. Realise it Mitch DeKoven Elisabeth H Hazard Erica Goldberg Shibani Pokras doi:10.1057/jcb.2008.7 Journal of Commercial Biotechnology 14, 299 (October 2008) April 15, 2008 Journal of Commercial Biotechnology April 15, 2008 14 4 299 306 Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice http://dx.doi.org/10.1057/jcb.2008.6 Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice

Journal of Commercial Biotechnology 14, 307 (October 2008). doi:10.1057/jcb.2008.6

Authors: Kerstin M Bode-Greuel, Klaus J Nickisch &

]]> Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice Kerstin M Bode-Greuel Klaus J Nickisch doi:10.1057/jcb.2008.6 Journal of Commercial Biotechnology 14, 307 (October 2008) March 4, 2008 Journal of Commercial Biotechnology March 4, 2008 14 4 307 325 Legal and Regulatory Update http://dx.doi.org/10.1057/jcb.2008.31 Legal and Regulatory Update

Journal of Commercial Biotechnology 14, 327 (October 2008). doi:10.1057/jcb.2008.31

]]> Legal and Regulatory Update doi:10.1057/jcb.2008.31 Journal of Commercial Biotechnology 14, 327 (October 2008) August 26, 2008 Journal of Commercial Biotechnology August 26, 2008 14 4 327 347 Intellectual Property and Biotechnology: Biological Inventions http://dx.doi.org/10.1057/jcb.2008.15 Intellectual Property and Biotechnology: Biological Inventions

Journal of Commercial Biotechnology 14, 349 (October 2008). doi:10.1057/jcb.2008.15

Author: Stefan M Miller

]]> Intellectual Property and Biotechnology: Biological Inventions Stefan M Miller doi:10.1057/jcb.2008.15 Journal of Commercial Biotechnology 14, 349 (October 2008) Journal of Commercial Biotechnology 14 4 349 351 Commercializing Successful Biomedical Technologies http://dx.doi.org/10.1057/jcb.2008.20 Commercializing Successful Biomedical Technologies

Journal of Commercial Biotechnology 14, 353 (October 2008). doi:10.1057/jcb.2008.20

Author: Arlen D Meyers

]]> Commercializing Successful Biomedical Technologies Arlen D Meyers doi:10.1057/jcb.2008.20 Journal of Commercial Biotechnology 14, 353 (October 2008) Journal of Commercial Biotechnology 14 4 353 354 Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences http://dx.doi.org/10.1057/jcb.2008.21 Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences

Journal of Commercial Biotechnology 14, 355 (October 2008). doi:10.1057/jcb.2008.21

Author: Arlen D Meyers &

]]> Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences Arlen D Meyers doi:10.1057/jcb.2008.21 Journal of Commercial Biotechnology 14, 355 (October 2008) Journal of Commercial Biotechnology 14 4 355 356 Biotechnology and the Law http://dx.doi.org/10.1057/jcb.2008.24 Biotechnology and the Law

Journal of Commercial Biotechnology 14, 357 (October 2008). doi:10.1057/jcb.2008.24

Author: Edward L Korwek

]]> Biotechnology and the Law Edward L Korwek doi:10.1057/jcb.2008.24 Journal of Commercial Biotechnology 14, 357 (October 2008) Journal of Commercial Biotechnology 14 4 357 358 Welcome to Biotech Nation http://dx.doi.org/10.1057/jcb.2008.23 Welcome to Biotech Nation

Journal of Commercial Biotechnology 14, 359 (October 2008). doi:10.1057/jcb.2008.23

Author: James Rogers

]]> Welcome to Biotech Nation James Rogers doi:10.1057/jcb.2008.23 Journal of Commercial Biotechnology 14, 359 (October 2008) Journal of Commercial Biotechnology 14 4 359 360 The Regulatory Challenge of Biotechnology http://dx.doi.org/10.1057/jcb.2008.26 The Regulatory Challenge of Biotechnology

Journal of Commercial Biotechnology 14, 361 (October 2008). doi:10.1057/jcb.2008.26

Author: John Avellanet

]]> The Regulatory Challenge of Biotechnology John Avellanet doi:10.1057/jcb.2008.26 Journal of Commercial Biotechnology 14, 361 (October 2008) Journal of Commercial Biotechnology 14 4 361 364 Best Practices in Biotechnology Business Development http://dx.doi.org/10.1057/jcb.2008.27 Best Practices in Biotechnology Business Development

Journal of Commercial Biotechnology 14, 365 (October 2008). doi:10.1057/jcb.2008.27

Author: Hans-Erik Hamid Lydecker &

]]> Best Practices in Biotechnology Business Development Hans-Erik Hamid Lydecker doi:10.1057/jcb.2008.27 Journal of Commercial Biotechnology 14, 365 (October 2008) Journal of Commercial Biotechnology 14 4 365 367 Genetic Glass Ceilings: Transgenics for Crop Biodiversity http://dx.doi.org/10.1057/jcb.2008.28 Genetic Glass Ceilings: Transgenics for Crop Biodiversity

Journal of Commercial Biotechnology 14, 369 (October 2008). doi:10.1057/jcb.2008.28

Author: Drew L Kershen

]]> Genetic Glass Ceilings: Transgenics for Crop Biodiversity Drew L Kershen doi:10.1057/jcb.2008.28 Journal of Commercial Biotechnology 14, 369 (October 2008) Journal of Commercial Biotechnology 14 4 369 370